VNT-101

N/A

Report date: 2023/09/22 17:32:53

Base Information

Drug NameVNT-101
Drug Alias NameVNT-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInfluenza Virus NS1A Binding Protein modulators
TargetsInfluenza Virus NS1A Binding Protein
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVia Nova Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesVia Nova Therapeutics LLCNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A